190 related articles for article (PubMed ID: 21168926)
1. Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans.
Otake H; Shite J; Ikeno F; Shinke T; Teramoto T; Miyoshi N; Ako J; Honda Y; Fitzgerald PJ; Hirata K
Int J Cardiol; 2012 May; 157(1):38-42. PubMed ID: 21168926
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography.
Li S; Wang Y; Gai L; Yang T; Liu H; Wang Z; Bai Q; Xu X; Chen Y
Int J Cardiol; 2013 Jan; 162(3):166-71. PubMed ID: 21641053
[TBL] [Abstract][Full Text] [Related]
3. Tissue coverage of paclitaxel and sirolimus eluting stents in long term follow-up: optical coherence tomography study.
Kochman J; Pietrasik A; Rdzanek A; Ścibisz A; Pawlak M; Filipiak KJ; Opolski G
Cardiol J; 2013; 20(3):247-53. PubMed ID: 23788298
[TBL] [Abstract][Full Text] [Related]
4. Different serial changes in the neointimal condition of sirolimus-eluting stents and paclitaxel-eluting stents: an optical coherence tomographic study.
Nakamura D; Lee Y; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y; Hara M; Sakata Y; Hamasaki T; Nishino M
EuroIntervention; 2014 Dec; 10(8):924-33. PubMed ID: 24602858
[TBL] [Abstract][Full Text] [Related]
5. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.
Toledano Delgado FJ; Alvarez-Ossorio MP; de Lezo Cruz-Conde JS; Bellido FM; Romero Moreno MÁ; Fernández-Aceytuno AM; de Lezo Herrerosde Tejada JS; Pineda SO; Saint-Gerons JM; Pavlovic D
Catheter Cardiovasc Interv; 2014 Nov; 84(5):720-6. PubMed ID: 24174291
[TBL] [Abstract][Full Text] [Related]
7. Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.
Takano M; Murakami D; Yamamoto M; Kurihara O; Murai K; Inami T; Kimata N; Ohba T; Seino Y; Mizuno K
Int J Cardiol; 2013 Jun; 166(1):181-6. PubMed ID: 22075410
[TBL] [Abstract][Full Text] [Related]
8. Two-year vessel healing after everolimus-eluting stent implantation: serial assessment by optical coherence tomography.
Taniguchi Y; Otake H; Shinke T; Nakagawa M; Hariki H; Inoue T; Osue T; Hiranuma N; Nishio R; Kinutani H; Iwasaki M; Konishi A; Kuroda M; Hirata K
J Cardiol; 2015 Apr; 65(4):298-304. PubMed ID: 25082295
[TBL] [Abstract][Full Text] [Related]
9. A serial 3- and 9-year optical coherence tomography assessment of vascular healing response to sirolimus- and paclitaxel-eluting stents.
Tomaniak M; Kołtowski Ł; Pietrasik A; Rdzanek A; Jąkała J; Proniewska K; Malinowski K; Mazurek T; Filipiak KJ; Brugaletta S; Opolski G; Kochman J
Int J Cardiovasc Imaging; 2019 Jan; 35(1):9-21. PubMed ID: 30168010
[TBL] [Abstract][Full Text] [Related]
10. Relationship between peri-strut low intensity areas and vascular healing response after everolimus-eluting bioresorbable scaffold implantation: An optical coherence tomography study.
Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
J Cardiol; 2017 Apr; 69(4):606-612. PubMed ID: 27520757
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.
Kim JS; Kim JS; Kim TH; Fan C; Lee JM; Kim W; Ko YG; Choi D; Hong MK; Jang Y
Circ J; 2010 Feb; 74(2):320-6. PubMed ID: 20019414
[TBL] [Abstract][Full Text] [Related]
13. Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.
Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
Int J Cardiol; 2013 Oct; 168(5):4617-23. PubMed ID: 23932862
[TBL] [Abstract][Full Text] [Related]
14. Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
Yoshimura T; Tanaka A; Mori N; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
Catheter Cardiovasc Interv; 2014 Nov; 84(5):742-9. PubMed ID: 24497273
[TBL] [Abstract][Full Text] [Related]
15. An optical coherence tomography study of two new generation stents with biodegradable polymer carrier, eluting paclitaxel vs. biolimus-A9.
Davlouros PA; Mavronasiou E; Xanthopoulou I; Karantalis V; Tsigkas G; Hahalis G; Alexopoulos D
Int J Cardiol; 2012 Jun; 157(3):341-6. PubMed ID: 21220173
[TBL] [Abstract][Full Text] [Related]
16. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure. - 6-month follow-up -.
Miyoshi N; Shite J; Shinke T; Otake H; Tanino Y; Ogasawara D; Sawada T; Kawamori H; Kato H; Yoshino N; Kozuki A; Hirata K
Circ J; 2010 May; 74(5):903-8. PubMed ID: 20215698
[TBL] [Abstract][Full Text] [Related]
17. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
[TBL] [Abstract][Full Text] [Related]
18. Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.
Koppara T; Tada T; Xhepa E; Kufner S; Byrne RA; Ibrahim T; Laugwitz KL; Kastrati A; Joner M
Int J Cardiol; 2018 May; 258():42-49. PubMed ID: 29544956
[TBL] [Abstract][Full Text] [Related]
19. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
[TBL] [Abstract][Full Text] [Related]
20. Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.
Kim TH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Int J Cardiovasc Imaging; 2011 Jul; 27(6):875-81. PubMed ID: 20978851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
